the National Advisory Committee on Immunization recommends RSV vaccination for adults aged 75 years and older, and adults aged 60 years and older who are residents of nursing homes and other chronic care facilities. One dose of an RSVvaccinehas been shown...
Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study inThe Lancetconcluded the vaccine is 80% effective at preventing hospitalization due to complic...
Older adults aren't the only group impacted by RSV. Very young children have been at the center of this winter's unusually severe RSV surge, which is now seeingcasesclimbing down from a steep peak. Pfizer also has amaternal vaccinein the race, which would be given to parents-to-be in ...
said in a statement: "Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV. Today's approval of the first RSV vaccine is an important public health achievement to preven...
The vaccines can be co-administered with COVID-19 and influenza vaccines in older adults, and the Abrysvo vaccine can be administered to pregnant women between 24 and 36 weeks gestation. However, the vaccines are not yet available on the National Immunisation Program...
vaccineeffectiveness in older adults in a retrospective case-control study. Cases were adults aged 60 years or older (mean age, 76.8 years) with hospitalizations or emergency department visits for LRTD from Nov. 24, 2023, to April 9, 2024, who had respiratory swabs collected and tested for ...
Around 1.5 cases of the syndrome per million doses given of GSK's vaccine have been reported, the CDCsaidlast week. The agency'ssurvey datahas found that close to a quarter of adults ages 60 and older had received an RSV shot since they were approved last year. ...
Pfizer and GSK have not released data on the effectiveness of their vaccine against severe RSV illness leading to hospitalization. MORE: Moderna says its RSV vaccine for older adults is 84% effective at preventing serious illness Side effects were mostly mild and included inje...
GSK releases strong efficacy data for older adult vaccine candidate RSV OA ahead of IDWeek2022 conference presentation.
older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care provider about whether RSV vaccination is the best course of action for ...